Previous 10 | Next 10 |
2023-10-25 13:19:48 ET DENVER, Colo., Oct. 25, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; BioXcel Therapeutics Inc (NASDAQ: BTAI), Abri SPAC I Inc (NASDAQ: ASPA), Deutsche Bank AG (NYSE: DB), ...
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is one of today's top gainers. The company's shares are currently up 23.93% on the day to $2.9. BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, utilizing artificial intelligence approaches to develop transformative medicines in ...
2023-10-25 10:04:33 ET A Connecticut-based %Biotech company is finding a ton of early success Wednesday morning after the company announced that an independent third-party review of the data from a site in its Tranquility II phase 3 trial showed “positive findings,” accord...
2023-10-25 09:59:18 ET DENVER, Colo., Oct. 25, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; BioXcel Therapeutics Inc (NASDAQ: BTAI), Abri SPAC I Inc (NASDAQ: ASPA), Deutsche Bank AG (NYSE: DB), Pagaya ...
2023-10-25 09:19:47 ET Whether you’re looking for the best penny stocks to buy, the most active stocks today, or just trying to plan out your next long-term investment, understanding things like stock market news and events is important. While some headlines can elicit short-...
2023-10-25 07:32:38 ET DENVER, Colo., Oct 25, 2023 ( www.247marketnews.com )- BioXcel Therapeutics Inc (NASDAQ: BTAI) reported, this morning, positive findings from an independent third-party audit of the data from a single site in its TRANQUILITY II Phase 3 trial. The independent audit...
2023-10-25 07:31:12 ET More on BioXcel Therapeutics BioXcel: Navigating The Peaks And Valleys Of Regulatory Uncertainties BioXcel's Struggles: From FDA Issues To Financial Instability BioXcel Therapeutics, Inc. (BTAI) Q2 2023 Earnings Call Transcript BioXcel ...
No evidence of misconduct or fraud found beyond instance previously reported 1 No findings identified that impact data integrity Company believes audit findings support reliability of positive TRANQUILITY II trial data and potential sNDA submission NEW HAVEN, Conn....
2023-10-11 08:28:56 ET More on Baxter, Denison Mines, etc. Denison Mines: Top Projects, Robust Balance Sheet, And Deeply Undervalued Denison Mines: A Promising Uranium Exploration Company Denison Mines: The Feasibility Study Demonstrates Wheeler's Potential D...
2023-10-10 12:19:25 ET What has been an otherwise bullish week was originally expected to become extremely volatile heading into mid-week. While things appear to be business as usual for a stock market rally could change quickly starting Wednesday, October 11th. What’s going on in th...
News, Short Squeeze, Breakout and More Instantly...
BioXcel Therapeutics Inc. Company Name:
BTAI Stock Symbol:
NASDAQ Market:
BioXcel Therapeutics Inc. Website:
Focused market-access strategy generates estimated net revenue of approximately $1.1 million, highest quarterly net revenue since commercial launch Represents 90% increase from the prior quarter and 141% increase from the second quarter of 2023 NEW HAVEN, Conn., July 16, 2024 (GLO...
Study achieved its objective and demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with 180 mcg dose (highest approved dose) For each episode occurring over seven days, a reduction in agitation was observed and no serious adverse events were reported following treatmen...
NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that CEO Vimal Mehta, Ph.D., will present at the Jef...